Loading clinical trials...
Loading clinical trials...
Impact of Aggressive Empiric Antibiotic Therapy and Duration of Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Hospitalized Subjects With Pneumonia Requiring Mechanical Ventilation
Conditions
Interventions
IV meropenem
I.V. Meropenem
+3 more
Locations
11
United States
InClin, Inc.
San Mateo, California, United States
UFL Department of Medicine: Pulmonary, Critical Care and Sleep Medicine
Gainesville, Florida, United States
Emory University
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
JMI Laboratories
North Liberty, Iowa, United States
Washington University in St. Louis School of Medicine
St Louis, Missouri, United States
Start Date
September 1, 2010
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
September 29, 2017
NCT06966284
NCT06804096
NCT07004049
NCT06162286
NCT06144996
NCT07386912
Lead Sponsor
University of Florida
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions